Skip to main content
Top
Published in: Cancer Cell International 1/2010

Open Access 01-12-2010 | Primary research

α-TEA-induced death receptor dependent apoptosis involves activation of acid sphingomyelinase and elevated ceramide-enriched cell surface membranes

Authors: Jing Li, Weiping Yu, Richa Tiwary, Sook-Kyung Park, Ailian Xiong, Bob G Sanders, Kimberly Kline

Published in: Cancer Cell International | Issue 1/2010

Login to get access

Abstract

Background

Alpha-tocopherol ether-linked acetic acid (α-TEA), an analog of vitamin E (RRR-alpha-tocopherol), is a potent and selective apoptosis-inducing agent for human cancer cells in vivo and in vitro. α-TEA induces apoptosis via activation of extrinsic death receptors Fas (CD95) and DR5, JNK/p73/Noxa pathways, and suppression of anti-apoptotic mediators Akt, ERK, c-FLIP and survivin in breast, ovarian and prostate cancer cells.

Results

In this study, we demonstrate that α-TEA induces the accumulation of cell surface membrane ceramide, leading to co-localization with Fas, DR5, and FADD, followed by activation of caspases-8 and -9 and apoptosis in human MDA-MB-231 breast cancer cells. α-TEA treatment leads to increased acid sphingomyelinase (ASMase) activity by 30 min, peaking at 4 hrs, which is correlated with ASMase translocation from cytosol to the cell surface membrane. Functional knockdown of ASMase with either the chemical inhibitor, desipramine, or siRNA markedly reduces α-TEA-induced cell surface membrane accumulation of ceramide and its co-localization with Fas, DR5, and FADD, cleavage of caspases-8 and -9 and apoptosis, suggesting an early and critical role for ASMase in α-TEA-induced apoptosis. Consistent with cell culture data, immunohistochemical analyses of tumor tissues taken from α-TEA treated nude mice bearing MDA-MB-231 xenografts show increased levels of cell surface membrane ceramide in comparison to tumor tissues from control animals.

Conclusion

Taken together, these studies demonstrate that ASMase activation and membrane ceramide accumulation are early events contributing to α-TEA-induced apoptosis in vitro and perhaps in vivo.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhang Y, Li X, Becker KA, Gulbins E: Ceramide-enriched membrane domains-structure and function. Biochim Biophys Acta. 2009, 1788: 178-83. 10.1016/j.bbamem.2008.07.030.CrossRefPubMed Zhang Y, Li X, Becker KA, Gulbins E: Ceramide-enriched membrane domains-structure and function. Biochim Biophys Acta. 2009, 1788: 178-83. 10.1016/j.bbamem.2008.07.030.CrossRefPubMed
2.
go back to reference Smith EL, Schuchman EH: The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 2008, 22: 3419-31. 10.1096/fj.08-108043.PubMedCentralCrossRefPubMed Smith EL, Schuchman EH: The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 2008, 22: 3419-31. 10.1096/fj.08-108043.PubMedCentralCrossRefPubMed
3.
go back to reference Carpinteiro A, Dumitru C, Schenck M, Gulbins E: Ceramide-induced cell death in malignant cells. Cancer Lett. 2008, 264: 1-10. 10.1016/j.canlet.2008.02.020.CrossRefPubMed Carpinteiro A, Dumitru C, Schenck M, Gulbins E: Ceramide-induced cell death in malignant cells. Cancer Lett. 2008, 264: 1-10. 10.1016/j.canlet.2008.02.020.CrossRefPubMed
4.
go back to reference Grassme H, Cremesti A, Kolesnick R, Gulbins E: Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene. 2003, 22: 5457-5470. 10.1038/sj.onc.1206540.CrossRefPubMed Grassme H, Cremesti A, Kolesnick R, Gulbins E: Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene. 2003, 22: 5457-5470. 10.1038/sj.onc.1206540.CrossRefPubMed
5.
go back to reference Dumitru CA, Carpinteiro A, Trarbach T, Hengge UR, Gulbins E: Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms. Apoptosis. 2007, 12: 1533-41. 10.1007/s10495-007-0081-9.CrossRefPubMed Dumitru CA, Carpinteiro A, Trarbach T, Hengge UR, Gulbins E: Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms. Apoptosis. 2007, 12: 1533-41. 10.1007/s10495-007-0081-9.CrossRefPubMed
6.
go back to reference Bollinger CR, Teichgraber V, Gulbins E: Ceramide-enriched membrane domains. Biochimica Biophysica Acta. 2005, 1746: 284-294.CrossRef Bollinger CR, Teichgraber V, Gulbins E: Ceramide-enriched membrane domains. Biochimica Biophysica Acta. 2005, 1746: 284-294.CrossRef
7.
go back to reference Wilson NS, Dixit V, Ashkenazi A: Death receptor signal transducers: nodes of coordination in immune signaling networks. Nature Immunol. 2009, 10: 348-55. 10.1038/ni.1714.CrossRef Wilson NS, Dixit V, Ashkenazi A: Death receptor signal transducers: nodes of coordination in immune signaling networks. Nature Immunol. 2009, 10: 348-55. 10.1038/ni.1714.CrossRef
8.
go back to reference Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995, 81: 505-12. 10.1016/0092-8674(95)90071-3.CrossRefPubMed Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995, 81: 505-12. 10.1016/0092-8674(95)90071-3.CrossRefPubMed
9.
go back to reference Grassme H, Schwarz H, Gulbins E: Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem Biophy Res Comm. 2001, 284: 1016-30. 10.1006/bbrc.2001.5045.CrossRef Grassme H, Schwarz H, Gulbins E: Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem Biophy Res Comm. 2001, 284: 1016-30. 10.1006/bbrc.2001.5045.CrossRef
10.
go back to reference Lawson KA, Anderson K, Simmons-Menchaca M: Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther. 2003, 2: 437-44.PubMed Lawson KA, Anderson K, Simmons-Menchaca M: Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther. 2003, 2: 437-44.PubMed
11.
go back to reference Lawson KA, Anderson K, Simmons-Menchaca M, Sun LZ, Sanders BG, Kline K: Comparison of vitamin E derivatives α-TEA and VES in reduction of mouse mammary tumor burden and metastasis. Exp Biol Med. 2004, 229: 954-63. Lawson KA, Anderson K, Simmons-Menchaca M, Sun LZ, Sanders BG, Kline K: Comparison of vitamin E derivatives α-TEA and VES in reduction of mouse mammary tumor burden and metastasis. Exp Biol Med. 2004, 229: 954-63.
12.
go back to reference Lawson KA, Anderson K, Snyder RM: Vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis. Cancer Chemother Pharmacol. 2004, 54: 421-31. 10.1007/s00280-004-0817-y.CrossRefPubMed Lawson KA, Anderson K, Snyder RM: Vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis. Cancer Chemother Pharmacol. 2004, 54: 421-31. 10.1007/s00280-004-0817-y.CrossRefPubMed
13.
go back to reference Zhang S, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K: Vitamin E analog α-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice. Breast Cancer Res Treat. 2004, 87: 111-21. 10.1023/B:BREA.0000041593.69178.57.CrossRefPubMed Zhang S, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K: Vitamin E analog α-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice. Breast Cancer Res Treat. 2004, 87: 111-21. 10.1023/B:BREA.0000041593.69178.57.CrossRefPubMed
14.
go back to reference Anderson K, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K: α-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis. Exp Biol Med. 2004, 229: 1169-76. Anderson K, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K: α-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis. Exp Biol Med. 2004, 229: 1169-76.
15.
go back to reference Yu W, Tiwary R, Li G, Park SK, Jia L, Xiong A, Simmons-Menchaca M, Sanders BG, Kline K: α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Mol. Carcinogenesis. 2010, Yu W, Tiwary R, Li G, Park SK, Jia L, Xiong A, Simmons-Menchaca M, Sanders BG, Kline K: α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Mol. Carcinogenesis. 2010,
16.
go back to reference Tiwary R, Yu W, Li J, Park SK, Sanders BG, Kline K: Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One. 2010, 29;5 (7): e11865-10.1371/journal.pone.0011865.CrossRef Tiwary R, Yu W, Li J, Park SK, Sanders BG, Kline K: Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One. 2010, 29;5 (7): e11865-10.1371/journal.pone.0011865.CrossRef
17.
go back to reference Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K: Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E succinate and vitamin E analogue, α-TEA. Cancer Res. 2004, 15: 4263-9. 10.1158/0008-5472.CAN-03-2327.CrossRef Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K: Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E succinate and vitamin E analogue, α-TEA. Cancer Res. 2004, 15: 4263-9. 10.1158/0008-5472.CAN-03-2327.CrossRef
18.
go back to reference Shun MC, Yu W, Gapor A: Pro-apoptotic mechanisms of action of a novel vitamin E analog (α-TEA) and a naturally occurring form of vitamin E (α-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer. 2004, 48: 95-105. 10.1207/s15327914nc4801_13.CrossRefPubMed Shun MC, Yu W, Gapor A: Pro-apoptotic mechanisms of action of a novel vitamin E analog (α-TEA) and a naturally occurring form of vitamin E (α-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer. 2004, 48: 95-105. 10.1207/s15327914nc4801_13.CrossRefPubMed
19.
go back to reference Hahn T, Szabo L, Gold M, Ramanathapuram L, Hurley LH, Akporiaye ET: Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Res. 2006, 66: 9374-8. 10.1158/0008-5472.CAN-06-2403.CrossRefPubMed Hahn T, Szabo L, Gold M, Ramanathapuram L, Hurley LH, Akporiaye ET: Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Res. 2006, 66: 9374-8. 10.1158/0008-5472.CAN-06-2403.CrossRefPubMed
20.
go back to reference Yu W, Shun M, Anderson K, Chen H, Sanders BG, Kline K: α-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Apoptosis. 2006, 11: 1813-23. 10.1007/s10495-006-9234-5.CrossRefPubMed Yu W, Shun M, Anderson K, Chen H, Sanders BG, Kline K: α-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Apoptosis. 2006, 11: 1813-23. 10.1007/s10495-006-9234-5.CrossRefPubMed
21.
go back to reference Jia L, Yu W, Wang P, Sanders BG, Kline K: Critical roles for JNK, c-Jun, and Fas/FasL-signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Prostate. 2008, 68: 427-41. 10.1002/pros.20716.CrossRefPubMed Jia L, Yu W, Wang P, Sanders BG, Kline K: Critical roles for JNK, c-Jun, and Fas/FasL-signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Prostate. 2008, 68: 427-41. 10.1002/pros.20716.CrossRefPubMed
22.
go back to reference Jia L, Yu W, Wang P, Sanders BG, Kline K: In vivo and in vitro studies of anticancer actions of α-TEA for human prostate cancer cells. Prostate. 2008, 68: 849-60. 10.1002/pros.20750.CrossRefPubMed Jia L, Yu W, Wang P, Sanders BG, Kline K: In vivo and in vitro studies of anticancer actions of α-TEA for human prostate cancer cells. Prostate. 2008, 68: 849-60. 10.1002/pros.20750.CrossRefPubMed
23.
go back to reference Yu W, Jia L, Park SK, Li J, Gopalan A, Simmons-Menchaca M, Sanders BG, Kline K: Anticancer actions of natural and synthetic vitamin E forms: RRR-alpha-tocopherol blocks the anticancer actions of gamma-tocopherol. Mol Nutr Food Res. 2009, 53: 1573-81. 10.1002/mnfr.200900011.PubMedCentralCrossRefPubMed Yu W, Jia L, Park SK, Li J, Gopalan A, Simmons-Menchaca M, Sanders BG, Kline K: Anticancer actions of natural and synthetic vitamin E forms: RRR-alpha-tocopherol blocks the anticancer actions of gamma-tocopherol. Mol Nutr Food Res. 2009, 53: 1573-81. 10.1002/mnfr.200900011.PubMedCentralCrossRefPubMed
24.
go back to reference Hahn T, Fried K, Hurley LH, Akporiaye ET: Orally active α-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer. Mol Cancer Ther. 2009, 8: 1570-8. 10.1158/1535-7163.MCT-08-1079.PubMedCentralCrossRefPubMed Hahn T, Fried K, Hurley LH, Akporiaye ET: Orally active α-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer. Mol Cancer Ther. 2009, 8: 1570-8. 10.1158/1535-7163.MCT-08-1079.PubMedCentralCrossRefPubMed
25.
go back to reference Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K: Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp Biol Med (Maywood). 2009, 234: 1244-52. 10.3181/0901-RM-8.CrossRef Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K: Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp Biol Med (Maywood). 2009, 234: 1244-52. 10.3181/0901-RM-8.CrossRef
26.
go back to reference Yu W, Israel K, Liao QY, Aldaz CM, Sanders BG, Kline K: Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res. 1999, 59: 953-61.PubMed Yu W, Israel K, Liao QY, Aldaz CM, Sanders BG, Kline K: Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res. 1999, 59: 953-61.PubMed
27.
go back to reference Yu W, Jia L, Park SK: Anticancer actions of natural and synthetic vitamin E forms: RRR-α-tocopherol blocks the anticancer actions of α-tocopherol. Mol Nutr Food Res. 2009, 53: 1573-1581. 10.1002/mnfr.200900011.PubMedCentralCrossRefPubMed Yu W, Jia L, Park SK: Anticancer actions of natural and synthetic vitamin E forms: RRR-α-tocopherol blocks the anticancer actions of α-tocopherol. Mol Nutr Food Res. 2009, 53: 1573-1581. 10.1002/mnfr.200900011.PubMedCentralCrossRefPubMed
28.
go back to reference Wang P, Yu W, Hu Z, Jia L, Iyer VR, Sanders BG, Kline K: Involvement of JNK/p73/NOXA in vitamin E analog-induced apoptosis of human breast cancer cells. Mol Carcinogen. 2008, 47: 436-45. 10.1002/mc.20400.CrossRef Wang P, Yu W, Hu Z, Jia L, Iyer VR, Sanders BG, Kline K: Involvement of JNK/p73/NOXA in vitamin E analog-induced apoptosis of human breast cancer cells. Mol Carcinogen. 2008, 47: 436-45. 10.1002/mc.20400.CrossRef
29.
go back to reference Snyder RM, Yu W, Jia L, Sanders BG, Kline K: Vitamin E analog α-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth. Nutr Cancer. 2008, 60: 401-11. 10.1080/01635580701759716.CrossRefPubMed Snyder RM, Yu W, Jia L, Sanders BG, Kline K: Vitamin E analog α-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth. Nutr Cancer. 2008, 60: 401-11. 10.1080/01635580701759716.CrossRefPubMed
30.
go back to reference Weber T, Dalen H, Andera L: Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochem. 2003, 42: 4277-91. 10.1021/bi020527j.CrossRef Weber T, Dalen H, Andera L: Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochem. 2003, 42: 4277-91. 10.1021/bi020527j.CrossRef
31.
go back to reference Gu X, Song X, Dong Y: Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res. 2008, 14: 1840-8. 10.1158/1078-0432.CCR-07-1811.CrossRefPubMed Gu X, Song X, Dong Y: Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res. 2008, 14: 1840-8. 10.1158/1078-0432.CCR-07-1811.CrossRefPubMed
32.
go back to reference Rotolo JA, Zhang J, Donepudi M, Lee H, Fuks Z, Kolesnick R: Caspase-dependent and -independent activation of acid sphingomyelinase signaling. J Biol Chem. 2005, 280: 26425-34. 10.1074/jbc.M414569200.CrossRefPubMed Rotolo JA, Zhang J, Donepudi M, Lee H, Fuks Z, Kolesnick R: Caspase-dependent and -independent activation of acid sphingomyelinase signaling. J Biol Chem. 2005, 280: 26425-34. 10.1074/jbc.M414569200.CrossRefPubMed
33.
go back to reference Dumitru CA, Gulbins E: TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene. 2006, 25: 5612-25. 10.1038/sj.onc.1209568.CrossRefPubMed Dumitru CA, Gulbins E: TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene. 2006, 25: 5612-25. 10.1038/sj.onc.1209568.CrossRefPubMed
34.
go back to reference Grassme H, Jekle A, Riehle A: CD95 signaling via ceramide-rich membrane rafts. J Biol Chem. 2001, 276: 20589-96. 10.1074/jbc.M101207200.CrossRefPubMed Grassme H, Jekle A, Riehle A: CD95 signaling via ceramide-rich membrane rafts. J Biol Chem. 2001, 276: 20589-96. 10.1074/jbc.M101207200.CrossRefPubMed
35.
go back to reference Radin NS: Killing tumors by ceramide-induced apoptosis: a critique of available drugs. Biochem J. 2003, 37: 243-256. 10.1042/BJ20021878.CrossRef Radin NS: Killing tumors by ceramide-induced apoptosis: a critique of available drugs. Biochem J. 2003, 37: 243-256. 10.1042/BJ20021878.CrossRef
36.
go back to reference Jin S, Yi F, Zhang F, Poklis JL, Li PL: Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler Thromb Vasc Biol. 2008, 28: 2056-62. 10.1161/ATVBAHA.108.172478.PubMedCentralCrossRefPubMed Jin S, Yi F, Zhang F, Poklis JL, Li PL: Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler Thromb Vasc Biol. 2008, 28: 2056-62. 10.1161/ATVBAHA.108.172478.PubMedCentralCrossRefPubMed
37.
go back to reference Zeidan YH, Hannun YA: Activation of acid sphingomyelinase by protein kinase C delta-mediated phosphorylation. J Biol Chem. 2007, 282: 11549-61. 10.1074/jbc.M609424200.CrossRefPubMed Zeidan YH, Hannun YA: Activation of acid sphingomyelinase by protein kinase C delta-mediated phosphorylation. J Biol Chem. 2007, 282: 11549-61. 10.1074/jbc.M609424200.CrossRefPubMed
38.
go back to reference Gulbins E: Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res. 2003, 47: 393-9. 10.1016/S1043-6618(03)00052-5.CrossRefPubMed Gulbins E: Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res. 2003, 47: 393-9. 10.1016/S1043-6618(03)00052-5.CrossRefPubMed
39.
go back to reference Charruyer A, Grazide S, Bezombes C, Muller S, Laurent G, Jaffrezou JP: UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently of a nuclear signal. J Biol Chem. 2005, 280: 19196-19204. 10.1074/jbc.M412867200.CrossRefPubMed Charruyer A, Grazide S, Bezombes C, Muller S, Laurent G, Jaffrezou JP: UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently of a nuclear signal. J Biol Chem. 2005, 280: 19196-19204. 10.1074/jbc.M412867200.CrossRefPubMed
40.
go back to reference Linke T, Wilkening G, Lansmann S: Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins. Biol Chem. 2001, 382: 283-90. 10.1515/BC.2001.035.CrossRefPubMed Linke T, Wilkening G, Lansmann S: Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins. Biol Chem. 2001, 382: 283-90. 10.1515/BC.2001.035.CrossRefPubMed
41.
go back to reference Kitatani K, Idkowiak-Baldys J, Hannun YA: The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008, 20: 1010-8. 10.1016/j.cellsig.2007.12.006.PubMedCentralCrossRefPubMed Kitatani K, Idkowiak-Baldys J, Hannun YA: The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008, 20: 1010-8. 10.1016/j.cellsig.2007.12.006.PubMedCentralCrossRefPubMed
42.
go back to reference Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN: gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci USA. 2004, 101: 17825-30. 10.1073/pnas.0408340102.PubMedCentralCrossRefPubMed Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN: gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci USA. 2004, 101: 17825-30. 10.1073/pnas.0408340102.PubMedCentralCrossRefPubMed
43.
go back to reference Kitatani K, Sheldon K, Rajagopalan V, Anelli V, Jenkins RW, Sun Y, Grabowski GA, Obeid LM, Hannun YA: Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation. J Biol Chem. 2009, 284: 12972-8. 10.1074/jbc.M802790200.PubMedCentralCrossRefPubMed Kitatani K, Sheldon K, Rajagopalan V, Anelli V, Jenkins RW, Sun Y, Grabowski GA, Obeid LM, Hannun YA: Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation. J Biol Chem. 2009, 284: 12972-8. 10.1074/jbc.M802790200.PubMedCentralCrossRefPubMed
44.
go back to reference Cowart LA, Szulc Z, Bielawska A, Hannun YA: Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies. J Lipid Res. 2002, 43: 2042-8. 10.1194/jlr.M200241-JLR200.CrossRefPubMed Cowart LA, Szulc Z, Bielawska A, Hannun YA: Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies. J Lipid Res. 2002, 43: 2042-8. 10.1194/jlr.M200241-JLR200.CrossRefPubMed
Metadata
Title
α-TEA-induced death receptor dependent apoptosis involves activation of acid sphingomyelinase and elevated ceramide-enriched cell surface membranes
Authors
Jing Li
Weiping Yu
Richa Tiwary
Sook-Kyung Park
Ailian Xiong
Bob G Sanders
Kimberly Kline
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2010
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-10-40

Other articles of this Issue 1/2010

Cancer Cell International 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine